Zhejiang Huixin

Zhejiang Huixin Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and high-end chemical intermediates. Founded in 2001 and headquartered in the pharmaceutical manufacturing hub of Linhai, Zhejiang, the company is a prominent global supplier of antihypertensive drugs, specifically within the "Sartan" family, including Valsartan and Irbesartan. In addition to its core cardiovascular portfolio, Huixin manufactures APIs for antiviral therapies such as Entecavir and Tenofovir, as well as antidiabetic medications like Vildagliptin. The company maintains state-of-the-art, GMP-compliant facilities and has successfully passed inspections by the US FDA and European regulatory bodies like the EDQM. Huixin also provides contract manufacturing (CMO) and custom synthesis services to global pharmaceutical partners, leveraging its expertise in complex organic synthesis and chiral chemistry.